WO2002057224A3 - Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' - Google Patents
Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' Download PDFInfo
- Publication number
- WO2002057224A3 WO2002057224A3 PCT/US2001/047238 US0147238W WO02057224A3 WO 2002057224 A3 WO2002057224 A3 WO 2002057224A3 US 0147238 W US0147238 W US 0147238W WO 02057224 A3 WO02057224 A3 WO 02057224A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- activityof
- antimicrobial
- synthesis
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002246600A AU2002246600B2 (en) | 2000-11-06 | 2001-11-06 | Synthesis and antimicrobial activity of novel dicationic "Reversed amidines" |
JP2002557905A JP2004517889A (en) | 2000-11-06 | 2001-11-06 | Synthesis and antibacterial activity of a novel dicationic "reverse amidine" |
EP01994174A EP1337510A4 (en) | 2000-11-06 | 2001-11-06 | Synthesis and antimicrobial activityof novel dicationic "reversed amidines" |
CA002425135A CA2425135A1 (en) | 2000-11-06 | 2001-11-06 | Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24624400P | 2000-11-06 | 2000-11-06 | |
US60/246,244 | 2000-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002057224A2 WO2002057224A2 (en) | 2002-07-25 |
WO2002057224A3 true WO2002057224A3 (en) | 2003-03-06 |
Family
ID=22929882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/047238 WO2002057224A2 (en) | 2000-11-06 | 2001-11-06 | Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1337510A4 (en) |
JP (1) | JP2004517889A (en) |
AU (1) | AU2002246600B2 (en) |
CA (1) | CA2425135A1 (en) |
WO (1) | WO2002057224A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737440B2 (en) | 2000-11-06 | 2004-05-18 | The University Of North Carolina At Chapel Hill | Synthesis and antimicrobial activity of novel dicationic “reversed amidines” |
WO2002036588A2 (en) * | 2000-11-06 | 2002-05-10 | U.S. Army Medical Research And Materiel Command | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
US6706754B2 (en) | 2000-11-06 | 2004-03-16 | The United States Of America As Represented By The Secretary Of The Army | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
EP1413301A1 (en) * | 2002-10-24 | 2004-04-28 | Bayer CropScience SA | Antifungal medicaments comprising arylamidine derivatives |
EP1565458A4 (en) * | 2002-11-27 | 2010-06-02 | Univ North Carolina | Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
AU2006202040A1 (en) * | 2005-05-20 | 2006-12-07 | Reto Brun | Novel biochalcophenes and their prodrugs as antiprotozoal agents |
US20100249175A1 (en) * | 2005-12-02 | 2010-09-30 | Wilson W David | Dicationic compounds which selectively recognize G-quadruplex DNA |
US9782388B2 (en) | 2014-02-25 | 2017-10-10 | University Of South Florida | BIS-cyclic guanidine compound compositions, methods of use and treatment thereof |
US20230105108A1 (en) * | 2019-12-19 | 2023-04-06 | Georgia State University Research Foundation, Inc. | Compounds for the treatment of bacterial infections and potentiation of antibiotics |
CN111362834B (en) * | 2020-02-26 | 2021-04-02 | 湖南大学 | Antibacterial amidine oligomer with drug resistance and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002036588A2 (en) * | 2000-11-06 | 2002-05-10 | U.S. Army Medical Research And Materiel Command | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
US20030199521A1 (en) * | 2001-01-13 | 2003-10-23 | Dykstra Christine C. | Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
WO2003017994A1 (en) * | 2001-08-31 | 2003-03-06 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
-
2001
- 2001-11-06 EP EP01994174A patent/EP1337510A4/en not_active Withdrawn
- 2001-11-06 AU AU2002246600A patent/AU2002246600B2/en not_active Ceased
- 2001-11-06 CA CA002425135A patent/CA2425135A1/en not_active Abandoned
- 2001-11-06 JP JP2002557905A patent/JP2004517889A/en active Pending
- 2001-11-06 WO PCT/US2001/047238 patent/WO2002057224A2/en not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
See also references of EP1337510A4 * |
STEPHENS C.E. ET AL.: "Diguanidino and 'reversed' diamidino 2,5-diarylfurans as antimicrobial agents", J. MED. CHEM., vol. 44, no. 11, 2001, pages 1741 - 1748, XP002955210 * |
Also Published As
Publication number | Publication date |
---|---|
CA2425135A1 (en) | 2002-07-25 |
EP1337510A2 (en) | 2003-08-27 |
AU2002246600B2 (en) | 2005-08-25 |
JP2004517889A (en) | 2004-06-17 |
WO2002057224A2 (en) | 2002-07-25 |
EP1337510A4 (en) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1288202A4 (en) | N-acyltetrahydroisoquinoline derivatives | |
CA2280753A1 (en) | 1,4-substituted cyclic amine derivatives | |
NO20052993L (en) | 4,5-diarylthiazole derivatives as CB-1 ligands. | |
MY129613A (en) | Cannabinoid receptor binding compounds | |
ATE396993T1 (en) | TETRAHYDROPYRANYL-CYCLOPENTYL-TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | |
EP0304493A4 (en) | Hydroxystyrene derivatives. | |
MY140390A (en) | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | |
CA2157117A1 (en) | Spirocyclic Piperidine Derivatives | |
DE69409525D1 (en) | ACETAMIDE DERIVATIVES AND THEIR USE AS A MODIFIER OF DIGESTION BEHAVIOR | |
CA2325741A1 (en) | Urea derivatives having tnf- .alpha. production inhibitory effects | |
CA2419194A1 (en) | Cyclopentyl modulators of chemokine receptor activity | |
ATE198319T1 (en) | SUCCINAMIDE DERIVATIVES AND THEIR USE AS METALPROTEINASE INHIBITORS | |
DE60322224D1 (en) | CONDENSED HETEROCYCLIC COMPOUNDS AS PETIDASE INHIBITORS | |
WO2004042351A3 (en) | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity | |
WO2002057224A3 (en) | Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' | |
SE9904108D0 (en) | New compounds | |
DE69505968T2 (en) | AZOLIDINDION DERIVATIVES AND THEIR USE AS ANTI-HYPERGLYCEMAS | |
MXPA05007671A (en) | Triazine derivatives as uv absorbers. | |
ATE359073T1 (en) | BENZYLIDENTHIAZOLIDINDIONES AND THEIR USE AS ANTIFUNGAL AGENTS | |
WO2004082616A3 (en) | Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity | |
WO2003057671A1 (en) | Biaryl compound and use thereof | |
IL136359A (en) | Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same | |
TR200200125T2 (en) | New aminothiazole derivatives, their preparation and pharmaceutical compositions containing them. | |
CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
TR200402650T4 (en) | New positive allosteric ampa-receptor modulators (paarms), methods for their manufacture and their use as pharmaceuticals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2425135 Country of ref document: CA Ref document number: 2002246600 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002557905 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001994174 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001994174 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002246600 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001994174 Country of ref document: EP |